Colon Cancer Is Second Leading Cause of Cancer in the U.S.
A radiation oncologist speaks about the prevalence of colon cancer.
A radiation oncologist speaks about the prevalence of colon cancer.
Stand Up To Cancer invites applications for participation in an Ideas Lab to establish the SU2C Head and Neck Cancer Research Team. The Research Team will bring new approaches to treating head and neck squamous cell carcinoma (HNSCC) cancer into the clinical setting, with a focus on HPV-related and Fanconi anemia (FA)-related cancers.
Stand Up To Cancer has received a $10 million grant from Exact Sciences, a leading developer of cancer screening tests, to promote colorectal cancer screenings in minority populations. The campaign will begin in March to coincide with National Colorectal Cancer Awareness Month.
Recently diagnosed cancer patients are more vulnerable to COVID-19 infection and face more severe illness than people without cancer, a risk that is significantly higher for Black people than for white people with both diseases, a large new analysis concludes.
Stand Up To Cancer has announced $3.25 million in grants from four nonprofits to fund research to find new treatments for head and neck cancers.
Stand Up To Cancer® (SU2C) today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly diagnosed in about 65,000 Americans every year.
Covid-19 stands as a litmus test for pushing the boundaries of standardized research processes.